Activation of P53 in HepG2 cells as surrogate to detect mutagens and promutagens in vitro

被引：27

作者：

Boehme, Kathleen ^{[1
]}

Dietz, Yasmin ^{[1
]}

Hewitt, Philip ^{[1
]}

Mueller, Stefan O. ^{[1
,2
]}

机构：

[1] Merck KGaA, Merck Serono, Toxicol, D-64293 Darmstadt, Germany

[2] Karlsruhe Inst Technol, Inst Angew Biowissensch, Karlsruhe, Germany

来源：

TOXICOLOGY LETTERS | 2010年 / 198卷 / 02期

关键词：

P53; HepG2; Mutagens; Promutagens; Genotoxicity; Metabolic activation; GENE-TOX PROGRAM; DISCRIMINATE RODENT CARCINOGENS; DRUG-METABOLIZING-ENZYMES; PRIMARY HUMAN HEPATOCYTES; MOUSE BONE-MARROW; MICRONUCLEUS TEST; GENOTOXICITY TESTS; HUMAN-LIVER; HEPATOCELLULAR-CARCINOMA; METHYL METHANESULFONATE;

D O I：

10.1016/j.toxlet.2010.07.007

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

The current genotoxicity tests of the standard in vitro battery, especially those using mammalian cells, are limited by their low specificity and highlight the importance of new in vitro tools. This study aimed to evaluate the suitability of HepG2 cells for assaying mutagens and promutagens. We determined P53 activity as surrogate genotoxicity endpoint in HepG2 cells. Our results revealed a significant P53-induction by actinomycin D, methyl methanesulfonate and etoposide. Prior to the investigation of promutagens we characterized HepG2 cells by analyzing the expression of 45 genes involved in xenobiotic metabolism and measuring the activity of selected Cytochrome-P450 (CYP) enzymes. We determined a limited metabolic capacity prompting us to employ a co-treatment with rat liver S9 as metabolic activation system (MAS) for promutagens. While cyclophosphamide showed an elevation of activated P53 in the presence of S9, 7,12-dimethylbenz[a]anthracene and aflatoxin B-1 responded without the MAS. Inhibition of cellular CYP3A4 or CYP1A/1B suppressed the aflatoxin B-1- and dimethylbenz[a]anthracene-mediated P53 response, respectively, indicating that HepG2 cells are capable of metabolizing these compounds in a CYP1A/B/3A4-dependent manner. In summary, our results indicate that P53 activation in HepG2 cells combined with a MAS can be used for the identification of new (pro)genotoxicants. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：272 / 281

页数：10

共 71 条

[41] COMPARISON OF S9 MIX AND HEPATOCYTES AS EXTERNAL METABOLIZING SYSTEMS IN MAMMALIAN-CELL CULTURES - CYTOGENETIC EFFECTS OF 7,12-DIMETHYLBENZANTHRACENE AND AFLATOXIN-B1 [J].

MADLE, E ;

TIEDEMANN, G ;

MADLE, S ;

OTT, A ;

KAUFMANN, G .

ENVIRONMENTAL MUTAGENESIS, 1986, 8 (03) :423-437

[42] Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU) [J].

Matsushima, T ;

Hayashi, M ;

Matsuoka, A ;

Ishidate, M ;

Miura, KF ;

Shimizu, H ;

Suzuki, Y ;

Morimoto, K ;

Ogura, H ;

Mure, K ;

Koshi, K ;

Sofuni, T .

MUTAGENESIS, 1999, 14 (06) :569-580

[43] THE INVIVO MICRONUCLEUS ASSAY IN MAMMALIAN BONE-MARROW AND PERIPHERAL-BLOOD - A REPORT OF THE UNITED-STATES-ENVIRONMENTAL-PROTECTION-AGENCY GENE-TOX PROGRAM [J].

MAVOURNIN, KH ;

BLAKEY, DH ;

CIMINO, MC ;

SALAMONE, MF ;

HEDDLE, JA .

MUTATION RESEARCH, 1990, 239 (01) :29-80

[44] The L5178Y/tk+/- mouse lymphoma specific gene and chromosomal mutation assay -: A phase III report of the US Environmental Protection Agency Gene-Tox program [J].

Mitchell, AD ;

Auletta, AE ;

Clive, D ;

Kirby, PE ;

Moore, MM ;

Myhr, BC .

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 394 (1-3) :177-303

[45] INDUCTION OF CYTOGENETIC ADAPTIVE RESPONSE OF MOUSE BONE-MARROW CELLS TO RADIATION BY THERAPEUTIC DOSES OF BLEOMYCIN SULFATE AND ACTINOMYCIN-D AS ASSAYED BY THE MICRONUCLEUS TEST [J].

MOZDARANI, H ;

SABERI, AH .

CANCER LETTERS, 1994, 78 (1-3) :141-150

[46] HOW DO INVIVO MAMMALIAN ASSAYS COMPARE TO INVITRO ASSAYS IN THEIR ABILITY TO DETECT MUTAGENS [J].

NATARAJAN, AT ;

OBE, G .

MUTATION RESEARCH, 1986, 167 (03) :189-201

[47] Effects of neonatally administered diethylstilbestrol on induction of mammary carcinomas induced by 7, 12-dimethylbenz[a]anthracene in female rats [J].

Ninomiya, Kenjiro ;

Kawaguchi, Hiroaki ;

Souda, Masakazu ;

Shuuhei, Taguchi ;

Funato, Mamoru ;

Umekita, Yoshihisa ;

Yoshida, Hiroki .

TOXICOLOGIC PATHOLOGY, 2007, 35 (06) :811-816

[48] Inhibition and induction of human cytochrome P450 (CYP) enzymes [J].

Pelkonen, O ;

Mäenpää, J ;

Taavitsainen, P ;

Rautio, A ;

Raunio, H .

XENOBIOTICA, 1998, 28 (12) :1203-1253

[49] Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes [J].

Richert, L. ;

Tuschl, G. ;

Abadie, C. ;

Blanchard, N. ;

Pekthong, D. ;

Mantion, G. ;

Weber, J. -C. ;

Mueller, S. O. .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) :86-96

[50] Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)butyric acid (EMD 392949) in vivo and in vitro [J].

Richert, Lysiane ;

Tuschl, Gregor ;

Viollon-Abadie, Catherine ;

Blanchard, Nadege ;

Bonet, Alexandre ;

Heyd, Bruno ;

Halkic, Nermin ;

Wimmer, Elmar ;

Dolgos, Hugues ;

Mueller, Stefan O. .

DRUG METABOLISM AND DISPOSITION, 2008, 36 (04) :702-714

← 1 2 3 4 5 6 7 8 →